Edwards Lifesciences Corporation
MX ˙ BMV ˙ US28176E1082
SecurityMX:EW / Edwards Lifesciences Corporation
InstitutionFisher Asset Management, LLC
Latest Disclosed Ownership132,199 shares
Latest Disclosed Value $ 10,586,526
Fisher Asset Management, LLC reports 9.23% decrease in ownership of EW / Edwards Lifesciences Corporation

On May 5, 2026 - Fisher Asset Management, LLC filed a 13F-HR form disclosing ownership of 132,199 shares of Edwards Lifesciences Corporation (MX:EW) valued at $10,586,526 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 9, 2026 disclosing 145,645 shares of Edwards Lifesciences Corporation. This represents a change in shares of -9.23% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 132,199 -13,446 -9.23 10,587 -14.74 0.0036
2026-02-09 2025-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 145,645 -101,775 -41.13 12,416 -35.47 0.0042
2025-11-12 2025-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 247,420 -68,972 -21.80 19,242 -22.24 0.0070
2025-08-13 2025-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 316,392 -9,784,074 -96.87 24,745 -96.62 0.0098
2025-05-14 2025-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 10,100,466 325,190 3.33 732,082 1.16 0.3169
2025-02-05 2024-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 9,775,276 696,965 7.68 723,664 20.80 0.2879
2024-11-12 2024-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 9,078,311 806,705 9.75 599,078 -21.59 0.2455
2024-08-14 2024-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 8,271,606 644,728 8.45 764,048 4.83 0.3324
2024-05-09 2024-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 7,626,878 498,599 6.99 728,825 34.09 0.3404
2024-03-05 2023-12-31 13F/A-1 EDWARDS LIFESCIENCES COM 28176E108 7,128,279 -186,188 -2.55 543,531 7.26 0.2874
2024-02-06 2023-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 7,133,892 -180,575 543,959 0.2678
2023-11-13 2023-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 7,314,467 -703,324 -8.77 506,746 -33.00 0.2874
2023-12-12 2023-06-30 13F/A-1 EDWARDS LIFESCIENCES COM 28176E108 8,017,791 198,252 2.54 756,318 16.91 0.4181
2023-08-08 2023-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 8,019,640 202,581 756 0.4180
2023-12-12 2023-03-31 13F/A-1 EDWARDS LIFESCIENCES COM 28176E108 7,819,539 146,921 1.91 646,911 112,996.15 0.3929
2023-05-01 2023-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 7,817,059 144,441 647 0.3916
2023-02-03 2022-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 7,672,618 133,880 1.78 572 -99.91 0.3870
2022-11-08 2022-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 7,538,738 208,057 2.84 622,926 -10.64 0.4669
2022-08-09 2022-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 7,330,681 227,736 3.21 697,075 -16.63 0.4933
2022-05-05 2022-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 7,102,945 320,643 4.73 836,159 -4.84 0.4933
2022-02-02 2021-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 6,782,302 357,605 5.57 878,647 20.80 0.4920
2021-10-26 2021-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 6,424,697 267,356 4.34 727,340 14.05 0.4518
2021-07-27 2021-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 6,157,341 334,627 5.75 637,716 30.94 0.4004
2021-04-27 2021-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 5,822,714 244,081 4.38 487,012 -4.31 0.3431
2021-01-29 2020-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 5,578,633 386,233 7.44 508,939 22.80 0.3813
2020-11-12 2020-09-30 13F/A-1 EDWARDS LIFESCIENCES COM 28176E108 5,192,400 204,982 4.11 414,457 20.24 0.3627
2020-11-10 2020-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 5,192,400 204,982 414,457 351,945.4758
2020-08-07 2020-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 4,987,418 3,632,715 268.16 344,680 34.89 0.3364
2020-04-28 2020-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 1,354,703 1,346,783 17,004.84 255,524 13,727.06 0.3169
2020-02-12 2019-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 7,920 -1,346 -14.53 1,848 -9.32 0.0019
2019-10-29 2019-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 9,266 2,141 30.05 2,038 54.86 0.0022
2019-07-30 2019-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 7,125 7,125 1,316 0.0015
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.